These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21055914)

  • 1. What is the role of harm reduction when drug users say they want abstinence?
    Neale J; Nettleton S; Pickering L
    Int J Drug Policy; 2011 May; 22(3):189-93. PubMed ID: 21055914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study.
    Neale J; Nettleton S; Pickering L
    Drug Alcohol Depend; 2013 Jan; 127(1-3):163-9. PubMed ID: 22809895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users.
    Best DW; Ghufran S; Day E; Ray R; Loaring J
    Drug Alcohol Rev; 2008 Nov; 27(6):619-24. PubMed ID: 19023771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young heroin users in Baltimore: a qualitative study.
    Gandhi DH; Kavanagh GJ; Jaffe JH
    Am J Drug Alcohol Abuse; 2006; 32(2):177-88. PubMed ID: 16595322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
    Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
    Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada.
    Cruz MF; Patra J; Fischer B; Rehm J; Kalousek K
    Int J Drug Policy; 2007 Jan; 18(1):54-61. PubMed ID: 17689344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Team research methods for studying intranasal heroin use and its HIV risks.
    Ouellet LJ; Wiebel WW; Jimenez AD
    NIDA Res Monogr; 1995; 157():182-211. PubMed ID: 8684437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors related to abstinence from drug use and seeking help from medical services in Taiwanese heroin and methamphetamine users.
    Yen CN; Tang TC; Liu SC; Liu BY; Chang HT; Yen CF
    Kaohsiung J Med Sci; 2008 Feb; 24(2):63-71. PubMed ID: 18281222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to methadone treatment: harm reduction in theory and practice.
    Järvinen M
    Sociol Health Illn; 2008 Nov; 30(7):975-91. PubMed ID: 18564977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
    Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
    J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction and 12 steps: complementary, oppositional, or something in-between?
    Lee HS; Engstrom M; Petersen SR
    Subst Use Misuse; 2011; 46(9):1151-61. PubMed ID: 21391893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'I don't think there's much of a rational mind in a drug addict when they are in the thick of it': towards an embodied analysis of recovering heroin users.
    Nettleton S; Neale J; Pickering L
    Sociol Health Illn; 2011 Mar; 33(3):341-55. PubMed ID: 21054440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'I just want to be normal': An analysis of discourses of normality among recovering heroin users.
    Nettleton S; Neale J; Pickering L
    Health (London); 2013 Mar; 17(2):174-90. PubMed ID: 22763795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of abstinence and activity in the quality of life of drug users engaged in treatment.
    Best D; Savic M; Beckwith M; Honor S; Karpusheff J; Lubman DI
    J Subst Abuse Treat; 2013 Sep; 45(3):273-9. PubMed ID: 23706622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.